Singapore - English - HSA (Health Sciences Authority)

blood services group, health sciences authority - human albumin - injection, solution, concentrate - 20.00% - human albumin 20%

Australia - English - Department of Health (Therapeutic Goods Administration)

iq medical - 61739 - corneal marker handpiece tip - a sterile device intended to be fitted to a corneal marker handpiece to directly ink mark corneal tissue prior to an ophthalmic surgical procedure. it is typically a small device preloaded with ink and is a single-use device.

Australia - English - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 61575 - skin marker pen, single-use, sterile - skin marker intended to be used to mark areas on the skin surface during surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

elitechgroup australia pty ltd - ct915 - cd cell marker (cluster of differentiation) ivds - ivds that are intended to be used as a complete process control for immunophenotyping by flow cytometry and also provide information about the presence and localisation of cell markers, collectively referred to as cd markers (cluster of differentiation) present on the surface of leukocytes.

Australia - English - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct915 - cd cell marker (cluster of differentiation) ivds - ivds that are intended to be used in histology and cytology to provide information about the presence and localisation of cell markers, collectively referred to as cd markers (cluster of differentiation) present on the surface of leukocytes.

Israel - English - Ministry of Health

a.l. medi-market ltd. - bivalirudin as trifluoroacetate - powder for concentrate for solution for injection / infusion - bivalirudin as trifluoroacetate 250 mg/vial - bivalirudin - bivalirudin medi-market 250 mg is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (pci) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - purified antigen fractions of inactivated split virions - a/indonesia/05/2005 (h5n1)/pr8-ibcdc-rg2 - injection, emulsion - 3.75 µg haemagglutinin/0.25 ml - purified antigen fractions of inactivated split virions - a/indonesia/05/2005 (h5n1)/pr8-ibcdc-rg2 3.75 µg haemagglutinin/0.25 ml

Israel - English - Ministry of Health

a.l. medi-market ltd. - esomeprazole as sodium - powder for solution for inj/inf - esomeprazole as sodium 40 mg/vial - esomeprazole - esomeprazole medi market for injection and infusion is indicated in adults for:• gastroesophageal reflux disease (gerd) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate. • prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. esomeprazole medi market for injection and infusion is indicated in children and adolescents aged 1-18 years for:• gastric antisecretory treatment when the oral route is not possible, such as:gastroesophageal reflux disease (gerd) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.

Israel - English - Ministry of Health

a.l. medi-market ltd. - ganciclovir as sodium - powder for concentrate for solution for infusion - ganciclovir as sodium 500 mg/vial - ganciclovir - ganciclovir medi-market 500 mg is indicated for the treatment of cmv retinitis in immunocompromised patiens, including patients with acquired immunodeficiency syndrome (aids). ganciclovir medi-market 500 mg is also indicated for the prevention of cmv disease in transplant recipients at risk for cmv disease.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - iron sucrose - solution for injection - iron sucrose 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - ferrovin is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb (haemoglobin),serum ferritin, tsat (transferrin saturation), serum iron, etc.).